Cargando…
Sclerostin Antibody Mitigates Estrogen Deficiency-Inducted Marrow Lipid Accumulation Assessed by Proton MR Spectroscopy
Sclerostin knock-out mice or sclerostin antibody (Scl-Ab) treated wild-type mice displayed decreased marrow adiposity. But the effects of Scl-Ab on estrogen deficiency-induced marrow fat expansion remain elusive. In this work, 45 female New Zealand rabbits were equally divided into sham-operation, o...
Autores principales: | Li, Shaojun, Huang, Bingcang, Jiang, Bo, Gu, Mingjun, Yang, Xiaodan, Yin, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436376/ https://www.ncbi.nlm.nih.gov/pubmed/30949129 http://dx.doi.org/10.3389/fendo.2019.00159 |
Ejemplares similares
-
Sclerostin and Osteocalcin: Candidate Bone-Produced Hormones
por: Wang, Jialiang S., et al.
Publicado: (2021) -
Associations Between Vertebral Marrow Proton Density Fat Fraction and Risk of Prostate Cancer
por: Li, Shaojun, et al.
Publicado: (2022) -
Associations of incidental vertebral fractures and longitudinal changes of MR–based proton density fat fraction and T2* measurements of vertebral bone marrow
por: Leonhardt, Yannik, et al.
Publicado: (2022) -
Decreased Sclerostin Secretion in Humans and Mice With Nonalcoholic Fatty Liver Disease
por: Zhou, Fangli, et al.
Publicado: (2021) -
Sclerostin as a biomarker of physical exercise in osteoporosis: A narrative review
por: Oniszczuk, Anna, et al.
Publicado: (2022)